Differences in reconstitution, storage, and administration technique can affect both the compound's effectiveness and its side effect profile
Topical percentage conversions Understanding what topical percentages mean helps compare products and DIY formulations
You know, that's what earning something looks like
But it just seemed that in trying to solve problems in medicine, not only did you get the satisfaction of solving them, but somebody else would benefit from that as well

Class Examples named by WADA Status GHRH analogs CJC-1293, CJC-1295, sermorelin, tesamorelin S2 prohibited at all times GH secretagogues and mimetics Anamorelin, capromorelin, ibutamoren (MK-677), ipamorelin, lenomorelin (ghrelin), macimorelin, tabimorelin S2 prohibited at all times GH-releasing peptides (GHRPs) Alexamorelin, examorelin (hexarelin), GHRP-1, GHRP-2 (pralmorelin), GHRP-3, GHRP-4, GHRP-6 S2 prohibited at all times Erythropoietin and EPO-receptor agonists Erythropoietins and agents affecting erythropoiesis S2 prohibited at all times Growth hormone and growth factors Growth hormone, IGF-1 and its analogs, and related growth factors affecting muscle, tendon or ligament S2 prohibited at all times Unapproved experimental peptides BPC-157 and similar compounds with no regulatory approval S0 prohibited at all times The S0 point is the one most often missed

Each peptide interacts with specific receptors expressed on particular cell types, creating targeted effects impossible with simple antioxidants or vitamins